Epilepsy with Myoclonic-Atonic Seizures Overview

Save information for later
Sign Up

Learn About Epilepsy with Myoclonic-Atonic Seizures

What is the definition of Epilepsy with Myoclonic-Atonic Seizures?
Epilepsy with myoclonic-atonic seizures is a rare epilepsy syndrome of early childhood. It is characterized by seizures of many different types, most often myoclonic-atonic, astatic, or generalized tonic-clonic seizures. Seizures can be followed by drop attacks, which can lead to falls and injuries. Absence seizures may occur. People with the condition may experience several seizures each day. The epilepsy may result in a delay or regression of skills. Autistic features and ataxic (poorly controlled) movements have been reported in some cases. Changes in the SCN1A, SCN1B, GABRG2, CHD2, and SLC6A1 genes can cause or contribute to Epilepsy with myoclonic-atonic seizures. However, in many cases the cause remains unknown. Epilepsy with myoclonic-atonic seizures can be inherited from an affected parent or occur for the first time in a family as a sporadic disease.
What are the alternative names for Epilepsy with Myoclonic-Atonic Seizures?
  • Epilepsy with myoclonic-atonic seizures
  • Doose syndrome
  • Epilepsy with myoclonic-astatic seizures
  • Epilepsy with myoclono-astatic crisis
  • Myoclonic astatic epilepsy
Who are the top Epilepsy with Myoclonic-Atonic Seizures Local Doctors?
Elite in Epilepsy with Myoclonic-Atonic Seizures
Dr. Orrin Devinsky
Neurology | General Surgery
Elite in Epilepsy with Myoclonic-Atonic Seizures
Dr. Orrin Devinsky
Neurology | General Surgery

New York University

223 E 34th St, 
New York, NY 
646-558-0800
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Orrin Devinsky is a Neurologist and a General Surgeon in New York, New York. Dr. Devinsky is rated as an Elite provider by MediFind in the treatment of Epilepsy with Myoclonic-Atonic Seizures. His top areas of expertise are Myoclonic Epilepsy, Dravet Syndrome, Seizures, Epilepsy, and Deep Brain Stimulation.

Elite in Epilepsy with Myoclonic-Atonic Seizures
Dr. Joseph E. Sullivan
Pediatric Neurology | Neurology
Elite in Epilepsy with Myoclonic-Atonic Seizures
Dr. Joseph E. Sullivan
Pediatric Neurology | Neurology
400 Parnassus Ave Fl 8, Box 0348, 
San Francisco, CA 
415-353-2437
Languages Spoken:
English
See accepted insurances

Joseph Sullivan is a Pediatric Neurologist and a Neurologist in San Francisco, California. Dr. Sullivan is rated as an Elite provider by MediFind in the treatment of Epilepsy with Myoclonic-Atonic Seizures. His top areas of expertise are Myoclonic Epilepsy, Dravet Syndrome, Epilepsy with Myoclonic-Atonic Seizures, and Epilepsy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Epilepsy with Myoclonic-Atonic Seizures
Rima Nabbout
Elite in Epilepsy with Myoclonic-Atonic Seizures
Rima Nabbout
Paris, FR 

Rima Nabbout practices in Paris, France. Ms. Nabbout is rated as an Elite expert by MediFind in the treatment of Epilepsy with Myoclonic-Atonic Seizures. Her top areas of expertise are Myoclonic Epilepsy, Dravet Syndrome, Epilepsy with Myoclonic-Atonic Seizures, and West Syndrome.

View All Doctors
What are the latest Epilepsy with Myoclonic-Atonic Seizures Clinical Trials?
EMPEROR: A Multicenter, Randomized, Double-blind, Sham-controlled, Parallel Group, Phase 3 Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen (STK-001) in Patients With Dravet Syndrome
EMPEROR: A Multicenter, Randomized, Double-blind, Sham-controlled, Parallel Group, Phase 3 Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen (STK-001) in Patients With Dravet Syndrome
Enrollment Status: Recruiting
Publish Date: October 08, 2025
Intervention Type: Drug, Other
Study Phase: Phase 3

Summary: The purpose of the study is to evaluate the efficacy, safety, and tolerability of zorevunersen in Patients with Dravet syndrome.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Observational, Prospective, Multicenter Study of Epidyolex® (Cannabidiol CBD 100 mg/ml) Oral Solution, as Adjunctive Treatment for Seizures Associated With Lennox- Gastaut Syndrome (LGS), Dravet Syndrome (DS) and Tuberous Sclerosis Complex (TSC)
Observational, Prospective, Multicenter Study of Epidyolex® (Cannabidiol CBD 100 mg/ml) Oral Solution, as Adjunctive Treatment for Seizures Associated With Lennox- Gastaut Syndrome (LGS), Dravet Syndrome (DS) and Tuberous Sclerosis Complex (TSC)
Enrollment Status: Recruiting
Publish Date: September 25, 2025
Intervention Type: Drug

Summary: This is a prospective, observational study on approximately 70-100 Real World participants affected by LGS, DS, or TSC treated with Epidyolex® as prescribed in the summary of product characteristics. The eligible participants are expected to participate in the study for a duration of 52 weeks of treatment.

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center